Target Gene/Pathway Pathway / Gene
Search results
No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related | KEGG GENES | KEGG DRUG | DrugBank | Disease ID | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | AGE-RAGE signaling pathway in diabetic complications 💬 1 gene, 1 drug (DrugBank) and 4 diseases |
TGFB2 [1] TGFB2 💬AGE-RAGE signaling pathway in diabetic complications
|
Fresolimumab Fresolimumab 💬AGE-RAGE signaling pathway in diabetic complications
| Fresolimumab | 051 [4] 51, 85, 222, 274 💬1. AGE-RAGE signaling pathway in diabetic complications
|
||||||||||||||||||
2 | Amoebiasis 💬 1 gene, 1 drug (DrugBank) and 4 diseases |
TGFB2 [1] TGFB2 💬AGE-RAGE signaling pathway in diabetic complications
|
Fresolimumab Fresolimumab 💬Amoebiasis
| Fresolimumab | 051 [4] 51, 85, 222, 274 💬1. AGE-RAGE signaling pathway in diabetic complications
|
||||||||||||||||||
3 | Cell cycle 💬 1 gene, 1 drug (DrugBank) and 4 diseases |
TGFB2 [1] TGFB2 💬AGE-RAGE signaling pathway in diabetic complications
|
Fresolimumab Fresolimumab 💬Cell cycle
| Fresolimumab | 051 [4] 51, 85, 222, 274 💬1. AGE-RAGE signaling pathway in diabetic complications
|
||||||||||||||||||
4 | Cellular senescence 💬 1 gene, 1 drug (DrugBank) and 4 diseases |
TGFB2 [1] TGFB2 💬AGE-RAGE signaling pathway in diabetic complications
|
Fresolimumab Fresolimumab 💬Cellular senescence
| Fresolimumab | 051 [4] 51, 85, 222, 274 💬1. AGE-RAGE signaling pathway in diabetic complications
|
||||||||||||||||||
5 | Chagas disease 💬 1 gene, 1 drug (DrugBank) and 4 diseases |
TGFB2 [1] TGFB2 💬AGE-RAGE signaling pathway in diabetic complications
|
Fresolimumab Fresolimumab 💬Chagas disease
| Fresolimumab | 051 [4] 51, 85, 222, 274 💬1. AGE-RAGE signaling pathway in diabetic complications
|
||||||||||||||||||
6 | Chronic myeloid leukemia 💬 1 gene, 1 drug (DrugBank) and 4 diseases |
TGFB2 [1] TGFB2 💬AGE-RAGE signaling pathway in diabetic complications
|
Fresolimumab Fresolimumab 💬Chronic myeloid leukemia
| Fresolimumab | 051 [4] 51, 85, 222, 274 💬1. AGE-RAGE signaling pathway in diabetic complications
|
||||||||||||||||||
7 | Colorectal cancer 💬 1 gene, 1 drug (DrugBank) and 4 diseases |
TGFB2 [1] TGFB2 💬AGE-RAGE signaling pathway in diabetic complications
|
Fresolimumab Fresolimumab 💬Colorectal cancer
| Fresolimumab | 051 [4] 51, 85, 222, 274 💬1. AGE-RAGE signaling pathway in diabetic complications
|
||||||||||||||||||
8 | Cytokine-cytokine receptor interaction 💬 1 gene, 1 drug (DrugBank) and 4 diseases |
TGFB2 [1] TGFB2 💬AGE-RAGE signaling pathway in diabetic complications
|
Fresolimumab Fresolimumab 💬Cytokine-cytokine receptor interaction
| Fresolimumab | 051 [4] 51, 85, 222, 274 💬1. AGE-RAGE signaling pathway in diabetic complications
|
||||||||||||||||||
9 | Diabetic cardiomyopathy 💬 1 gene, 1 drug (DrugBank) and 4 diseases |
TGFB2 [1] TGFB2 💬AGE-RAGE signaling pathway in diabetic complications
|
Fresolimumab Fresolimumab 💬Diabetic cardiomyopathy
| Fresolimumab | 051 [4] 51, 85, 222, 274 💬1. AGE-RAGE signaling pathway in diabetic complications
|
||||||||||||||||||
10 | Dilated cardiomyopathy 💬 1 gene, 1 drug (DrugBank) and 4 diseases |
TGFB2 [1] TGFB2 💬AGE-RAGE signaling pathway in diabetic complications
|
Fresolimumab Fresolimumab 💬Dilated cardiomyopathy
| Fresolimumab | 051 [4] 51, 85, 222, 274 💬1. AGE-RAGE signaling pathway in diabetic complications
|
||||||||||||||||||
11 | FoxO signaling pathway 💬 1 gene, 1 drug (DrugBank) and 4 diseases |
TGFB2 [1] TGFB2 💬AGE-RAGE signaling pathway in diabetic complications
|
Fresolimumab Fresolimumab 💬FoxO signaling pathway
| Fresolimumab | 051 [4] 51, 85, 222, 274 💬1. AGE-RAGE signaling pathway in diabetic complications
|
||||||||||||||||||
12 | Gastric cancer 💬 1 gene, 1 drug (DrugBank) and 4 diseases |
TGFB2 [1] TGFB2 💬AGE-RAGE signaling pathway in diabetic complications
|
Fresolimumab Fresolimumab 💬Gastric cancer
| Fresolimumab | 051 [4] 51, 85, 222, 274 💬1. AGE-RAGE signaling pathway in diabetic complications
|
||||||||||||||||||
13 | Hepatitis B 💬 1 gene, 1 drug (DrugBank) and 4 diseases |
TGFB2 [1] TGFB2 💬AGE-RAGE signaling pathway in diabetic complications
|
Fresolimumab Fresolimumab 💬Hepatitis B
| Fresolimumab | 051 [4] 51, 85, 222, 274 💬1. AGE-RAGE signaling pathway in diabetic complications
|
||||||||||||||||||
14 | Hepatocellular carcinoma 💬 1 gene, 1 drug (DrugBank) and 4 diseases |
TGFB2 [1] TGFB2 💬AGE-RAGE signaling pathway in diabetic complications
|
Fresolimumab Fresolimumab 💬Hepatocellular carcinoma
| Fresolimumab | 051 [4] 51, 85, 222, 274 💬1. AGE-RAGE signaling pathway in diabetic complications
|
||||||||||||||||||
15 | Hippo signaling pathway 💬 1 gene, 1 drug (DrugBank) and 4 diseases |
TGFB2 [1] TGFB2 💬AGE-RAGE signaling pathway in diabetic complications
|
Fresolimumab Fresolimumab 💬Hippo signaling pathway
| Fresolimumab | 051 [4] 51, 85, 222, 274 💬1. AGE-RAGE signaling pathway in diabetic complications
|
||||||||||||||||||
16 | Human T-cell leukemia virus 1 infection 💬 1 gene, 1 drug (DrugBank) and 4 diseases |
TGFB2 [1] TGFB2 💬AGE-RAGE signaling pathway in diabetic complications
|
Fresolimumab Fresolimumab 💬Human T-cell leukemia virus 1 infection
| Fresolimumab | 051 [4] 51, 85, 222, 274 💬1. AGE-RAGE signaling pathway in diabetic complications
|
||||||||||||||||||
17 | Hypertrophic cardiomyopathy 💬 1 gene, 1 drug (DrugBank) and 4 diseases |
TGFB2 [1] TGFB2 💬AGE-RAGE signaling pathway in diabetic complications
|
Fresolimumab Fresolimumab 💬Hypertrophic cardiomyopathy
| Fresolimumab | 051 [4] 51, 85, 222, 274 💬1. AGE-RAGE signaling pathway in diabetic complications
|
||||||||||||||||||
18 | Inflammatory bowel disease 💬 1 gene, 1 drug (DrugBank) and 4 diseases |
TGFB2 [1] TGFB2 💬AGE-RAGE signaling pathway in diabetic complications
|
Fresolimumab Fresolimumab 💬Inflammatory bowel disease
| Fresolimumab | 051 [4] 51, 85, 222, 274 💬1. AGE-RAGE signaling pathway in diabetic complications
|
||||||||||||||||||
19 | Leishmaniasis 💬 1 gene, 1 drug (DrugBank) and 4 diseases |
TGFB2 [1] TGFB2 💬AGE-RAGE signaling pathway in diabetic complications
|
Fresolimumab Fresolimumab 💬Leishmaniasis
| Fresolimumab | 051 [4] 51, 85, 222, 274 💬1. AGE-RAGE signaling pathway in diabetic complications
|
||||||||||||||||||
20 | Malaria 💬 1 gene, 1 drug (DrugBank) and 4 diseases |
TGFB2 [1] TGFB2 💬AGE-RAGE signaling pathway in diabetic complications
|
Fresolimumab Fresolimumab 💬Malaria
| Fresolimumab | 051 [4] 51, 85, 222, 274 💬1. AGE-RAGE signaling pathway in diabetic complications
|
||||||||||||||||||
21 | MAPK signaling pathway 💬 1 gene, 1 drug (DrugBank) and 4 diseases |
TGFB2 [1] TGFB2 💬AGE-RAGE signaling pathway in diabetic complications
|
Fresolimumab Fresolimumab 💬MAPK signaling pathway
| Fresolimumab | 051 [4] 51, 85, 222, 274 💬1. AGE-RAGE signaling pathway in diabetic complications
|
||||||||||||||||||
22 | MicroRNAs in cancer 💬 1 gene, 1 drug (DrugBank) and 4 diseases |
TGFB2 [1] TGFB2 💬AGE-RAGE signaling pathway in diabetic complications
|
Fresolimumab Fresolimumab 💬MicroRNAs in cancer
| Fresolimumab | 051 [4] 51, 85, 222, 274 💬1. AGE-RAGE signaling pathway in diabetic complications
|
||||||||||||||||||
23 | Osteoclast differentiation 💬 1 gene, 1 drug (DrugBank) and 4 diseases |
TGFB2 [1] TGFB2 💬AGE-RAGE signaling pathway in diabetic complications
|
Fresolimumab Fresolimumab 💬Osteoclast differentiation
| Fresolimumab | 051 [4] 51, 85, 222, 274 💬1. AGE-RAGE signaling pathway in diabetic complications
|
||||||||||||||||||
24 | Pancreatic cancer 💬 1 gene, 1 drug (DrugBank) and 4 diseases |
TGFB2 [1] TGFB2 💬AGE-RAGE signaling pathway in diabetic complications
|
Fresolimumab Fresolimumab 💬Pancreatic cancer
| Fresolimumab | 051 [4] 51, 85, 222, 274 💬1. AGE-RAGE signaling pathway in diabetic complications
|
||||||||||||||||||
25 | Pathways in cancer 💬 1 gene, 1 drug (DrugBank) and 4 diseases |
TGFB2 [1] TGFB2 💬AGE-RAGE signaling pathway in diabetic complications
|
Fresolimumab Fresolimumab 💬Pathways in cancer
| Fresolimumab | 051 [4] 51, 85, 222, 274 💬1. AGE-RAGE signaling pathway in diabetic complications
|
||||||||||||||||||
26 | Proteoglycans in cancer 💬 1 gene, 1 drug (DrugBank) and 4 diseases |
TGFB2 [1] TGFB2 💬AGE-RAGE signaling pathway in diabetic complications
|
Fresolimumab Fresolimumab 💬Proteoglycans in cancer
| Fresolimumab | 051 [4] 51, 85, 222, 274 💬1. AGE-RAGE signaling pathway in diabetic complications
|
||||||||||||||||||
27 | Renal cell carcinoma 💬 1 gene, 1 drug (DrugBank) and 4 diseases |
TGFB2 [1] TGFB2 💬AGE-RAGE signaling pathway in diabetic complications
|
Fresolimumab Fresolimumab 💬Renal cell carcinoma
| Fresolimumab | 051 [4] 51, 85, 222, 274 💬1. AGE-RAGE signaling pathway in diabetic complications
|
||||||||||||||||||
28 | Rheumatoid arthritis 💬 1 gene, 1 drug (DrugBank) and 4 diseases |
TGFB2 [1] TGFB2 💬AGE-RAGE signaling pathway in diabetic complications
|
Fresolimumab Fresolimumab 💬Rheumatoid arthritis
| Fresolimumab | 051 [4] 51, 85, 222, 274 💬1. AGE-RAGE signaling pathway in diabetic complications
|
||||||||||||||||||
29 | TGF-beta signaling pathway 💬 1 gene, 1 drug (DrugBank) and 4 diseases |
TGFB2 [1] TGFB2 💬AGE-RAGE signaling pathway in diabetic complications
|
Fresolimumab Fresolimumab 💬TGF-beta signaling pathway
| Fresolimumab | 051 [4] 51, 85, 222, 274 💬1. AGE-RAGE signaling pathway in diabetic complications
|
||||||||||||||||||
30 | Toxoplasmosis 💬 1 gene, 1 drug (DrugBank) and 4 diseases |
TGFB2 [1] TGFB2 💬AGE-RAGE signaling pathway in diabetic complications
|
Fresolimumab Fresolimumab 💬Toxoplasmosis
| Fresolimumab | 051 [4] 51, 85, 222, 274 💬1. AGE-RAGE signaling pathway in diabetic complications
|
||||||||||||||||||
31 | Tuberculosis 💬 1 gene, 1 drug (DrugBank) and 4 diseases |
TGFB2 [1] TGFB2 💬AGE-RAGE signaling pathway in diabetic complications
|
Fresolimumab Fresolimumab 💬Tuberculosis
| Fresolimumab | 051 [4] 51, 85, 222, 274 💬1. AGE-RAGE signaling pathway in diabetic complications
|
AGE-RAGE signaling pathway in diabetic complications
1 gene, 1 drug (DrugBank) and 4 diseases
Amoebiasis
1 gene, 1 drug (DrugBank) and 4 diseases
Cell cycle
1 gene, 1 drug (DrugBank) and 4 diseases
Cellular senescence
1 gene, 1 drug (DrugBank) and 4 diseases
Chagas disease
1 gene, 1 drug (DrugBank) and 4 diseases
Chronic myeloid leukemia
1 gene, 1 drug (DrugBank) and 4 diseases
Colorectal cancer
1 gene, 1 drug (DrugBank) and 4 diseases
Cytokine-cytokine receptor interaction
1 gene, 1 drug (DrugBank) and 4 diseases
Diabetic cardiomyopathy
1 gene, 1 drug (DrugBank) and 4 diseases
Dilated cardiomyopathy
1 gene, 1 drug (DrugBank) and 4 diseases
FoxO signaling pathway
1 gene, 1 drug (DrugBank) and 4 diseases
Gastric cancer
1 gene, 1 drug (DrugBank) and 4 diseases
Hepatitis B
1 gene, 1 drug (DrugBank) and 4 diseases
Hepatocellular carcinoma
1 gene, 1 drug (DrugBank) and 4 diseases
Hippo signaling pathway
1 gene, 1 drug (DrugBank) and 4 diseases
Human T-cell leukemia virus 1 infection
1 gene, 1 drug (DrugBank) and 4 diseases
Hypertrophic cardiomyopathy
1 gene, 1 drug (DrugBank) and 4 diseases
Inflammatory bowel disease
1 gene, 1 drug (DrugBank) and 4 diseases
Leishmaniasis
1 gene, 1 drug (DrugBank) and 4 diseases
Malaria
1 gene, 1 drug (DrugBank) and 4 diseases
MAPK signaling pathway
1 gene, 1 drug (DrugBank) and 4 diseases
MicroRNAs in cancer
1 gene, 1 drug (DrugBank) and 4 diseases
Osteoclast differentiation
1 gene, 1 drug (DrugBank) and 4 diseases
Pancreatic cancer
1 gene, 1 drug (DrugBank) and 4 diseases
Pathways in cancer
1 gene, 1 drug (DrugBank) and 4 diseases
Proteoglycans in cancer
1 gene, 1 drug (DrugBank) and 4 diseases
Renal cell carcinoma
1 gene, 1 drug (DrugBank) and 4 diseases
Rheumatoid arthritis
1 gene, 1 drug (DrugBank) and 4 diseases
TGF-beta signaling pathway
1 gene, 1 drug (DrugBank) and 4 diseases
Toxoplasmosis
1 gene, 1 drug (DrugBank) and 4 diseases
Tuberculosis
1 gene, 1 drug (DrugBank) and 4 diseases